Clearside Biomedical's total assets for Q2 2025 were $15.33M, a decrease of -22.05% from the previous quarter. CLSD total liabilities were $64.07M for the fiscal quarter, a -2.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.